SEC Form 4 · accession 0001022079-18-000155
QUEST DIAGNOSTICS INC · DGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael E Prevoznik
Officer — SVP & General Counsel
Period of report
Jul 10, 2018
Accepted (ET)
Jul 12, 2018 · 4:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001022079
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 10, 2018 | M | 30,780 | $57.605 | A | 70,551 | D | |
| Common StockF2,F3 | Jul 10, 2018 | S | 30,780 | $113.065 | D | 39,791 | D | |
| Common StockF4 | holding | — | — | — | 4,915 | I | 401(k)/SDCP |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F5 | $57.605 | Jul 10, 2018 | M | 30,780 | D | — | Feb 27, 2022 | Common Stock | 30,780 | 0 | D |
Explanation of responses
- F1This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on June 4, 2018.
- F2This transaction was executed in multiple trades at prices ranging from $113.00 to $113.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.
- F4These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
- F5The options vested in three equal annual installments beginning with the first on February 27, 2013, the second on February 27, 2014 and the final on February 27, 2015.